Kaushik Desai

ORCID: 0000-0001-9355-4528
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Glycation End Products research
  • Nitric Oxide and Endothelin Effects
  • Eicosanoids and Hypertension Pharmacology
  • Biochemical effects in animals
  • Alcohol Consumption and Health Effects
  • Diet, Metabolism, and Disease
  • Natural Antidiabetic Agents Studies
  • Renin-Angiotensin System Studies
  • Fatty Acid Research and Health
  • Neuroscience of respiration and sleep
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Adipose Tissue and Metabolism
  • Cardiovascular Function and Risk Factors
  • Sulfur Compounds in Biology
  • Prostate Cancer Treatment and Research
  • Amino Acid Enzymes and Metabolism
  • Diet and metabolism studies
  • Plant and fungal interactions
  • Biochemical Acid Research Studies
  • Pancreatic function and diabetes
  • Muscle metabolism and nutrition
  • Systemic Sclerosis and Related Diseases
  • Inflammatory Myopathies and Dermatomyositis
  • Antioxidant Activity and Oxidative Stress
  • Regulation of Appetite and Obesity

University of Saskatchewan
2011-2024

Biotech Park
2023

Emory University
2021-2022

Wake Forest University
2021

Forest Institute
2021

Institute of Cancer Research
2019-2021

Emory University Hospital
2021

University of Pennsylvania
2018-2020

Philadelphia VA Medical Center
2019

St.John's Medical College Hospital
2017

Nitric oxide produced in endothelial cells affects vascular tone. To investigate the role of nitric synthase (eNOS) blood pressure regulation, we have generated mice heterozygous (+/−) or homozygous (−/−) for disruption eNOS gene. Immunohistochemical staining with anti-eNOS antibodies showed reduced amounts protein +/− and absence −/− mutant mice. Male female all three genotypes were indistinguishable general appearance histology, except that had lower body weights than +/+ Blood pressures...

10.1073/pnas.93.23.13176 article EN Proceedings of the National Academy of Sciences 1996-11-12

Patients with type 2 diabetes mellitus (T2DM) have reduced platelet inhibition compared non-diabetics following P2Y12 receptor blockade. Whether of signalling can be enhanced by adjunctive treatment cilostazol in T2DM patients is unknown. The aim this pilot study was to assess the functional impact on standard aspirin and clopidogrel treatment. This a prospective, double-blind, double-dummy, placebo-controlled, randomized, cross-over function study. dual antiplatelet therapy were assigned...

10.1093/eurheartj/ehn287 article EN European Heart Journal 2008-03-13

OBJECTIVE The incidence of high dietary carbohydrate-induced type 2 diabetes is increasing worldwide. Methylglyoxal (MG) a reactive glucose metabolite and major precursor advanced glycation end products (AGEs). MG levels are elevated in diabetic patients. We investigated the effects chronic administration on tolerance β-cell insulin secreting mechanism 12-week-old male Sprague-Dawley rats. RESEARCH DESIGN AND METHODS (60 mg/kg/day) or 0.9% saline was administered by continuous infusion with...

10.2337/db10-0627 article EN cc-by-nc-nd Diabetes 2011-02-08

The pathogenic process of diabetes mellitus is associated with increased methylglyoxal (MG). MG causes non-enzymic glycation proteins to form irreversible advanced endproducts (AGEs). However, the correlation between and essential hypertension unknown. aim present study was investigate whether MG, MG-induced AGEs, oxidative stress were in aorta spontaneously hypertensive rats (SHR) an formation related AGEs correlated development high blood pressure these rats.High-performance liquid...

10.1097/01.hjh.0000173778.85233.1b article EN Journal of Hypertension 2005-07-07

Endothelial dysfunction is a feature of hypertension and diabetes. Methylglyoxal (MG) reactive dicarbonyl metabolite glucose its levels are elevated in spontaneously hypertensive rats diabetic patients. We investigated if MG induces endothelial whether scavengers can prevent induced by high concentrations.Endothelium-dependent relaxation was studied aortic rings from Sprague-Dawley rats. also used cultured rat human umbilical vein cells. The measured HPLC Western blotting assay kits were...

10.1111/j.1476-5381.2010.01017.x article EN British Journal of Pharmacology 2010-09-03

Alagebrium is a breaker of cross-links in advanced glycation endproducts. However, the acute effects alagebrium on methylglyoxal (MG), major precursor endproducts have not been reported. MG highly reactive endogenous metabolite, and its levels are elevated diabetic patients. We investigated whether attenuated exogenous plasma levels, glucose tolerance distribution administered different organs Sprague-Dawley rats.We measured (by HPLC), tolerance, adipose tissue uptake, GLUT4, insulin...

10.1111/j.1476-5381.2009.00469.x article EN British Journal of Pharmacology 2009-12-04

Here we show that the relaxation induced by stimulation of vagus nerve in presence cholinergic (muscarinic) and adrenergic blockade isolated stomach guinea pig is mediated nitric oxide (NO). This substantiated inhibition vagal NG-monomethyl-L-arginine, an inhibitor NO synthesis. The effect NG-monomethyl-L-arginine was partially reversed coincubation with L-arginine but not D-arginine. activates soluble guanylate cyclase, prevented methylene blue, further supporting our conclusions. relaxant...

10.1073/pnas.88.24.11490 article EN Proceedings of the National Academy of Sciences 1991-12-15

Methylglyoxal is a reactive dicarbonyl intermediate of metabolism produced in the body. It reacts with certain proteins and forms damaging advanced glycation endproducts (AGEs) such as N epsilon-carboxyethyl-lysine (CEL) epsilon-carboxymethyl-lysine (CML). Increased methylglyoxal levels are found diabetes mellitus associated hypertension development spontaneously hypertensive rats (SHR). The purpose this study was to investigate whether increased endogenous formation methylglyoxal-induced...

10.1097/hjh.0b013e3282f4a13c article EN Journal of Hypertension 2008-04-01

Methylglyoxal (MG) overproduction has been reported in metabolic syndrome with hyperglycaemia (diabetes) or without (hypertension), and the underlying mechanism was investigated. Contributions of different pathways enzymes to MG formation were evaluated aorta cultured vascular smooth muscle cells (VSMCs). In all four animal models syndrome, i.e. chronically fructose-fed hypertensive Sprague–Dawley rats, spontaneously obese non-diabetic Zucker diabetic serum aortic fructose levels increased,...

10.1093/cvr/cvr239 article EN Cardiovascular Research 2011-09-02

The current epidemic of obesity and type 2 diabetes is attributed to a high carbohydrate diet, containing mainly fructose corn syrup sucrose. More than two thirds diabetic patients have hypertension. Methylglyoxal highly reactive dicarbonyl generated during glucose metabolism, major precursor advanced glycation end products (AGEs). Plasma methylglyoxal levels are increased in hypertensive rats patients. Our aim was examine the methylglyoxal, mediators renin angiotensin system blood pressure...

10.1371/journal.pone.0074212 article EN cc-by PLoS ONE 2013-09-10

Methylglyoxal (MG), a metabolite of glucose, and MG-induced advanced glycation endproducts (AGEs) are causatively associated with vascular complications diabetes mellitus. We have previously reported elevated levels MG AGEs in spontaneously hypertensive rats (SHR). The purpose this study was to investigate the causative role pathogenesis hypertension SHR. Young SHR were treated an AGE inhibitor, aminoguanidine, for 9 weeks. HPLC used determine plasma aortic reduced glutathione levels. AGEs,...

10.1016/j.amjhyper.2006.12.003 article EN American Journal of Hypertension 2007-05-31

Methylglyoxal (MG), a reactive metabolite of glucose, has high affinity for arginine and is precursor advanced glycation endproducts (AGEs). We tested the hypothesis that l-arginine, its inactive isomer d-arginine, can efficiently scavenge MG, administered exogenously or produced endogenously from attenuate harmful effects including endothelial dysfunction oxidative stress by an nitric-oxide synthase (eNOS)-independent mechanism. used isolated aortic rings 12-week-old male Sprague-Dawley...

10.1124/jpet.112.192112 article EN Journal of Pharmacology and Experimental Therapeutics 2012-04-19

To investigate the mechanism underlying observation that infusion of growth hormone secretagogue peptide, ghrelin, produces a decrease in mean arterial pressure (MAP) with no change heart rate.The effect single bolus ghrelin (12 nmol/kg intravenously) on changes MAP and rate was determined 12-week-old male anaesthetized Sprague-Dawley rats subjected to pretreatment either nitric oxide synthase (NOS) inhibitor, N-nitro-L-arginine methyl ester (L-NAME; 0.7 mg/ml by mouth for 5 days), or...

10.1097/01.hjh.0000163146.20330.bc article EN Journal of Hypertension 2005-03-16
Coming Soon ...